GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » DeferredTaxAndRevenue

Minapharm Pharmaceuticals (CAI:MIPH) DeferredTaxAndRevenue : E£0 Mil (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Minapharm Pharmaceuticals's current deferred tax and revenue for the quarter that ended in Sep. 2024 was E£0 Mil.

Minapharm Pharmaceuticals DeferredTaxAndRevenue Historical Data

The historical data trend for Minapharm Pharmaceuticals's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals DeferredTaxAndRevenue Chart

Minapharm Pharmaceuticals Annual Data
Trend Dec22 Dec23
DeferredTaxAndRevenue
- -

Minapharm Pharmaceuticals Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

Minapharm Pharmaceuticals DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Minapharm Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY
Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines